Marc J Spirn MD
Retinal Disease
Assistant Professor, Ophthalmology, Jefferson Medical College-Thos Jefferson Univ
Join to View Full Profile
4060 Butler PikeSuite200Plymouth Meeting, PA 19462
Phone+1 800-331-6634
Fax+1 267-420-1360
Dr. Spirn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineResidency, Ophthalmology, 2003 - 2006
NYU Grossman School of MedicineInternship, Internal Medicine, 2002 - 2003
Rutgers Robert Wood Johnson Medical SchoolClass of 2002
Certifications & Licensure
DE State Medical License Current
PA State Medical License 2006 - 2026
NJ State Medical License 2007 - 2025
GA State Medical License 2004 - 2007
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion Start of enrollment: 2011 Sep 01
- Thrombospondin-1 and Pigmented Epithelium Derived Factor Levels in Patients With Diabetes Mellitus. Start of enrollment: 2010 Mar 01
- Eye Injections of Bevacizumab for Lowering Risk of Scar Tissue in the Retina and Repeated Retinal Detachment. Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- Rhegmatogenous Retinal Detachment Following Vitrectomy and Subretinal Tissue Plasminogen Activator for Submacular Hemorrhage.Jordan P Safran, Bita Momenaei, Jonathan Martin, Benjamin Crain, Collin Richards
Retina. 2025-01-29 - 2 citationsLong-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection.Asad F Durrani, Bita Momenaei, Viren Soni, Matthew Tennant, Jason Hsu
Journal of Ocular Pharmacology and Therapeutics. 2024-11-01 - 7 citationsConversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema.Asad Farooq Durrani, Bita Momenaei, Taku Wakabayashi, Sudheshna Vemula, Saagar A Pandit
The British Journal of Ophthalmology. 2024-08-22
Journal Articles
- Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular DegenerationSamir N Patel, Jeremy D Wolfe, Sunir J Garg, Marc J Spirn, James F Vander, JAMA Ophthalmology
- Effect of Adjuvant Topical Dorzolamide-Timolol vs Placebo in Neovascular Age-Related Macular DegenerationSamir N Patel, Jeremy D Wolfe, Sunir J Garg, Marc J Spirn, James F Vander, JAMA Ophthalmology
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
